CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating expenses:
Research and development	$ 15,414	$ 11,473
General and administrative	6,248	6,195
Total operating expenses	21,662	17,668
Loss from operations	(21,662)	(17,668)
Other income (expense), net:
Interest income	1,996	1,446
Other expense, net	(14)	(264)
Total other income, net	1,982	1,182
Net loss	$ (19,680)	$ (16,486)
Net loss per share—basic	$ (0.51)	$ (0.73)
Net loss per share—diluted	$ (0.51)	$ (0.73)
Weighted-average common stock outstanding—basic	38,350,444	22,590,804
Weighted-average common stock outstanding—diluted	38,350,444	22,590,804
Comprehensive loss:
Net Income (Loss)	$ (19,680)	$ (16,486)
Other comprehensive income (loss):
Unrealized (loss) gain on available-for-sale investments, net of tax	(164)	13
Comprehensive loss	$ (19,844)	$ (16,473)